UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 1, 2024
Accession Number:
0001193125-24-077783
Submission Type:
POS AM
CIK:
0001636282
Company Name:
Spyre Therapeutics, Inc.
File Number:
333-273769